We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
On the 24 March 2017 the World Health Organisation (WHO) reported
that as of the 19 March 2017 a total of 1407 suspected cases on meningitis and 211 deaths have been reported in Nigeria from December 2016.
Cases have been reported from 40 local government areas (LGAs) in five states of Nigeria; Zamfara, Katsina and Sokoto account for 89% of these cases. Three of these LGAs share borders with Niger. Approximately half of the reported cases are in the age group 5 to 14 years old, both sexes are equally affected.
The Nigeria Centers for Disease Control and Prevention, with support from WHO, is coordinating the response at national level. Public health interventions include rapid response teams which are involved in active case finding and training local staff on case management, and mass vaccination campaigns.
Spread through airborne droplets and direct contact with nasal/pharyngeal secretions of infected individuals or carriers. Meningococcal disease is found worldwide but epidemics may occur in this country, which lies within the extended meningitis belt of Africa, particularly during the dry season. If vaccination is recommended, quadrivalent conjugate vaccine should be used.
Consider vaccinating:
